Page - 21 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Image of the Page - 21 -
Text of the Page - 21 -
Condeetal. Biofunctionalizationandsurfacechemistryof inorganicnanoparticles
affinity recognition, andcovalent coupling, eachofwhichhas its
ownadvantages anddisadvantages. In this sectionof the review,
the several coupling strategies for biofunctionalization of gold,
MNPsandQDswillbeexamined.
Covalentstrategies
Covalent coupling provides stable and strong binding of the
biomolecules to the NPs. Most proteins have amine groups in
their surface, so they canbedirectly conjugated toNPs contain-
ing reactive groups such as aldehydes, epoxides or anhydrides
(Fuentesetal., 2005;Luetal., 2008).
Ontheotherhand,couplingofNPsthatexhibitaminegroups
with molecules containing aldehydes or epoxides can also be
used.However, some biomolecules such as antibodies, oligonu-
cleotides, carbohydrates or peptides do not include these func-
tional groups, and should bemodified prior to the conjugation
(Nobs et al., 2004). For instance, carbohydrates present in some
antibodies can be oxidized using periodate to generate aldehyde
groups that can reactwith the aminogroupspresent on theNPs
surface (Fuentes et al., 2005). Nevertheless, chemical modifica-
tionmay compromise biomolecules’ activity, so oneof themost
frequentways to conjugatemolecules to theNPs is using linker
molecules.
EDC coupling reaction. 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) is a zero-length crosslinking agent used to
couple carboxyl or phosphate groups to primary amines, which
may react with a carboxyl group of a biomolecule, forming an
amine-reactive O-acylisourea intermediate. Addition of sulfo-
NHS stabilizes the amine-reactive intermediate by converting it
to an amine-reactive sulfo-NHS ester. The O-acylisourea inter-
mediatemay also reactwith an amineona secondbiomolecule,
producingaconjugateof the twobiomolecules joinedbya stable
amide bond. This crosslinker has been used in diverse appli-
cations, such as conjugation of carboxyl to amine groups in
peptides and proteins, forming amide bonds in peptide synthe-
sis, attachinghaptens to carrierproteins and form immunogens,
labeling nucleic acids through 5′ phosphate groups and creat-
ing amine-reactive NHS-esters of biomolecules (Grabarek and
Gergely,1990).
One of themain advantages of EDC coupling is water solu-
bility, which allows direct bioconjugationwithout prior organic
solvent dissolution. On top of that, the excess of reagents and
by-products can be easily removed by dialysis or gel-filtration
(Sheehan et al., 1965). However, the coupling reaction has to
be carried out fast, as the reactive ester that is formed can be
rapidly hydrolyzed in aqueous solutions. To increase the sta-
bility of this active ester, N-hydroxysuccinimide (NHS) or N-
hydroxysulfoxuccinimide (sulfo-NHS) can be used (Jang and
Keng, 2008). Key parameters that should be controlled when
usingEDCarepH(ashydrolysis is largelydependentonpH), the
amountofEDCso thatNPsdonotaggregatedue to lossof elec-
trostatic repulsive forces betweenNPs, and the ratio EDC/NHS
(NakajimaandIkada,1995;Sametal., 2009;Shenetal., 2009).
Using this protocol almost all kinds of molecules (i.e.,
enzymes, antibodies, peptides,DNA, fluorophores, etc.)may be
attached to the nanoparticle surfacewithout priormodification FIGURE8 |EDCcouplingreaction.The1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) is a zero-lengthcrosslinkingagentused tocouple
carboxyl groups toprimaryamines. In thepresenceof
N-hydroxysulfosuccinimide (Sulfo-NHS),EDCcanbeused toconvert
carboxyl groups toamine-reactiveSulfo-NHSesters. Theadditionof
Sulfo-NHSstabilizes theamine-reactive intermediatebyconverting it toan
amine-reactiveSulfo-NHSester, thus increasing theefficiencyof
EDC-mediatedcoupling reactions.Excess reagentandcrosslinkingby
productsareeasily removedbywashingwithwater.OnceEDC iswater
soluble, thecrosslinkingcanbedoneunderphysiologic conditionswithout
addingorganicsolvent.
(seeFigure8) (Pandey et al., 2007; Susumuet al., 2007; Rostro-
Kohanloo et al., 2009; Conde et al., 2012a; Lavilla et al., 2012).
For instance,usingtheEDCchemistry,Weisslederandcoworkers
createdalibraryofMNPsdecoratedwithdifferentsyntheticsmall
molecules for the development ofmagnetofluorescent reporters
(Weissleder et al., 2005). Using these fluorescent MNPs it was
possible to screen against different cell types or among differ-
ent physiological states of a cell line. On the other hand, Sanz
et al. have reported the effect of biofunctional spacers, such as
thiolated PEG chains on the loading of RNAmolecules and a
positive peptide functionalized by EDC coupling reactions on
the surface ofAuNPs (Sanz et al., 2012). Lin and coworkers also
used EDC to attach CH3O-PEG-NH2 to different types of car-
boxylated NPs (MNPs, QDs) demonstrating that adjusting the
ratio EDC/NP it was possible to prepare NPs with 0, 1, or 2
attached PEGmolecules (Lin et al., 2008). Similarly, Parak and
co-workers alsousedEDC to attachNH2–PEG–NH2molecules,
varying the molecular weight of the polymer on the surface
of AuNPs (Sperling et al., 2006; Pellegrino et al., 2007). The
covalent attaching of biofunctional short PEGmolecules to the
polymer shell produces very stable particles in electrolytic solu-
tion. This approach results in stablewater-soluble AuNPs (Sanz
etal.,2012)andQDs(Ballouetal.,2004)withfunctionalgroups,
e.g. −COOH or −NH2 on the free ends of PEG molecules.
By controlling the EDC ratio, aggregationwas prevented. Dhar
et al. have exploited the rapid intracellular uptake of AuNPs to
deliverandactivatecisplatinandachieveefficientcytosolicdeliv-
ery of platinum(IV) prodrug to lung cancer cells. The AuNPs
used in this study were functionalized with thiolated oligonu-
cleotides containing a terminal dodecyl amine for conjugation
Frontiers inChemistry | ChemicalEngineering July2014 |Volume2 |Article48 | 21
Cancer Nanotheranostics
What Have We Learnd So Far?
- Title
- Cancer Nanotheranostics
- Subtitle
- What Have We Learnd So Far?
- Authors
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Editor
- Frontiers in Chemistry
- Date
- 2016
- Language
- English
- License
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Size
- 21.0 x 27.7 cm
- Pages
- 132
- Keywords
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Categories
- Naturwissenschaften Chemie